Metis TechBio Signs Up to $1.1 Billion Deal With Eli Lilly
Metis TechBio said it entered a collaboration agreement with Eli Lilly for research and development of tissue-specific drug delivery technologies. The deal is worth up to $1.1 billion.
Hong Kong-listed Metis TechBio HKEX:7666 said on Monday it had entered into a collaboration agreement with Eli Lilly NYSE:LLY for research and development of tissue-specific drug delivery technologies. The deal is worth up to $1.1 billion.